DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) General Information

Description

A number of drug product candidates' rights are intended to be used for the treatment of opiate addiction and alcohol abuse. The drugs work as an antagonist that blocks receptors in the brain and to be taken once-a-month intramuscular injection.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1430 Obrien Drive
  • Suite E
  • Menlo Park, CA 94025
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 1430 Obrien Drive
  • Suite E
  • Menlo Park, CA 94025
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)‘s full profile, request access.

Request a free trial

DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)‘s full profile, request access.

Request a free trial

DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) FAQs

  • Where is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) headquartered?

    DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is headquartered in Menlo Park, CA.

  • What industry is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) in?

    DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s primary industry is Buildings and Property.

  • Is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) a private or public company?

    DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is a Private company.

  • What is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s current revenue?

    The current revenue for DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is .

  • Who are DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s investors?

    DrugAbuse Sciences has invested in DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights).

  • When was DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) acquired?

    DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) was acquired on 19-Jan-2007.

  • Who acquired DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)?

    DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) was acquired by Elbion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process